FDA declines to endorse leucovorin for autism, approves it for cerebral folate deficiency
The prescription drug leucovorin is getting a label update, but it’s not what that the US Food and Drug Administration suggested during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism. On Tuesday, the FDA approved the high-dose B vitamin — a treatment … Read more